Skip to main content
Livermore
Livermore
ZHEN

Allogene Therapeutics, Inc.

ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737287

In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Allogene Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ALLO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders1611192+32
Shares100.8M636106.3M+5.47M (+5.4%)
Value$1.15B$0$1.15B−$1.92M (−0.2%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ALLO in Q3 2022
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc535,368$5.78M0.05%
Point72 Asset Management, L.P.293,200$3.17M0.01%
Squarepoint Ops LLC246,322$2.66M0.02%
Twinbeech Capital LP195,435$2.11M0.06%
Jump Financial, LLC126,366$1.36M0.05%
Moore Capital Management, LP119,972$1.30M0.04%
Qube Research & Technologies Ltd117,057$1.26M0.01%
HRT Financial LP110,259$1.19M0.01%
Swedbank AB105,500$1.14M0.00%
Diametric Capital, LP85,343$922.0K0.46%
Aquatic Capital Management LLC80,000$864.0K0.08%
Public Employees Retirement System of Ohio51,979$561.0K0.00%
Engineers Gate Manager LP48,144$520.0K0.03%
Dynamic Technology Lab Private Ltd46,452$501.0K0.05%
Balyasny Asset Management LLC41,479$448.0K0.00%
Hanseatic Management Services Inc39,340$425.0K1.15%
XTX Topco Ltd38,642$417.0K0.10%
Raymond James & Associates35,138$379.0K0.00%
Boulder Hill Capital Management LP35,000$378.0K0.29%
Prelude Capital Management, LLC33,707$364.0K0.02%
Gsa Capital Partners LLP31,846$344.0K0.05%
Russell Investments Group, Ltd.26,668$287.0K0.00%
Seven Eight Capital, LP26,013$281.0K0.06%
First Trust Advisors LP24,595$266.0K0.00%
Virtu Financial LLC24,128$261.0K0.02%
Virginia Retirement Systems Et Al21,900$236.5K0.00%
Bridgefront Capital, LLC20,512$222.0K0.23%
American Century Companies Inc16,997$184.0K0.00%
Tudor Investment Corp Et Al17,053$184.0K0.00%
Fox Run Management, L.L.C.15,215$164.0K0.06%
Quantbot Technologies LP13,700$147.0K0.01%
Marshall Wace, LLP12,593$136.0K0.00%
Bailard, Inc.11,600$125.0K0.01%
Allspring Global Investments Holdings, LLC3,228$34.0K0.00%
Simplex Trading, LLC2,050$22.0K0.00%
Van Eck Associates Corp1,838$20.0K0.00%
China Universal Asset Management Co., Ltd.1,347$15.0K0.01%
Wipfli Financial Advisors LLC,243$3.00K0.00%
CWM, LLC40$00.00%
Allworth Financial LP37$00.00%
JFS Wealth Advisors, LLC11$00.00%
Disciplined Investments, LLC4$00.00%
SJS Investment Consulting Inc.3$00.00%
Schubert & Co9$00.00%

Sold out (12)

Institutions that held Allogene Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ALLO in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Ergoteles LLC76,675$874.0K
Connor, Clark & Lunn Investment Management Ltd.46,106$526.0K
Connective Portfolio Management, LLC30,000$342.0K
Y-Intercept (Hong Kong) Ltd18,422$210.0K
Jupiter Asset Management Ltd17,868$204.0K
Trexquant Investment LP14,853$169.0K
Victory Capital Management Inc14,525$166.0K
CIBC World Markets Inc.12,170$139.0K
HSBC Holdings PLC11,500$131.0K
Profund Advisors LLC10,229$117.0K
Captrust Financial Advisors461$5.00K
Prospera Financial Services Inc222$3.00K

Not filed for Q3 2022 yet (1)

Institutions that held Allogene Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALLO in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
B. Riley Wealth Management, Inc.636–